Article tools
Author information

Research Article

Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat.

A A Rossini, D Faustman, B A Woda, A A Like, I Szymanski and J P Mordes

Published July, 1984

The Bio-Breeding/Worcester (BB/W) rat develops spontaneous autoimmune diabetes similar to human insulin-dependent diabetes mellitus. Transfusions of whole blood from the nondiabetic W-line of BB/W rats prevent the syndrome in diabetes-prone recipients. We report three experiments designed to determine which blood component is protective. In all experiments, diabetes-prone BB/W rats 23 to 35 d of age were given four or six weekly intravenous injections. In the first experiment, animals received either saline or transfusions of erythrocytes, white blood cells, or plasma from W-line donors. Diabetes occurred in 7/22 (32%) erythrocyte, 2/27 (7%) white cell, 14/24 (58%) plasma, and 15/27 (56%) saline recipients (P less than 0.001). At 120 d of age, peripheral blood was obtained from nondiabetic rats. Fluorescence-activated cell sorter analysis of OX 19 tagged leucocytes revealed 35% T lymphocytes in white cell recipients (n = 13), compared with 9% in saline recipients (n = 7; P less than 0.001). Responsiveness to concanavalin A was also increased in the white cell group, whereas the frequency of both insulitis and thyroiditis was decreased. In the second experiment, 1/19 (5%) rats transfused with W-line spleen cells developed diabetes, as contrasted with 12/18 (67%) recipients of diabetes-prone spleen cells and 19/31 (61%) noninjected controls (P less than 0.001). In the third experiment, diabetes-prone rats received either W-line blood treated with a cytotoxic anti-T lymphocyte antibody plus complement, untreated blood, or saline. Diabetes occurred in 8/20 (40%), 1/20 (5%), and 13/19 (68%) rats in each group, respectively (P less than 0.001). We conclude that transfusions of W-line T lymphocytes prevent diabetes in the BB/W rat.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Articles that cite
this article:

The BB rat
John P. Mordes, James Desemone, Aldo A. Rossini
Diabetes Metab Rev 3(3):725. [CrossRef]

Autoimmune diabetes mellitus in the BB rat
Laura Crisá, John P. Mordes, Aldo A. Rossini
Diabetes Metab Rev 8(1):9. [CrossRef]

Experimental immunoprevention of type I diabetes mellitus
Christian Boitard, José Timsit, Pascal Sempé, Jean-FrançOis Bach
Diabetes Metab Rev 7(1):15. [CrossRef]

Cell-mediated autoimmunity in type I diabetes
Jose Barbosa, Fritz H. Bach
Diabetes Metab Rev 3(4):981. [CrossRef]

Contrasuppression in autoimmunity
Carolyn J. Kelly, Eric G. Neilson
IR 7(1):56. [CrossRef]

Immunological concepts in insulin-dependent (Type I) diabetes mellitus
Amos Etzioni
IR 6(3):215. [CrossRef]

The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse
I. R. Cohen, V. Ablamunits, D. Elias
Clin Exp Immunol 115(2):260. [CrossRef]

Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat
J. P. Mordes, D. L. Gallina, E. S. Handler, D. L. Greiner, N. Nakamura, A. Pelletier, A. A. Rossini
Diabetologica 30(1):22. [CrossRef]

Transforming growth factor‐β and T‐cell‐mediated immunoregulation in the control of autoimmune diabetes
Sylvaine You, Nathalie Thieblemont, Marie‐Alexandra Alyanakian, Jean‐Francois Bach, Lucienne Chatenoud
Immunol Rev 212(1):185. [CrossRef]

Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A
Hans J. Hahn, Silke Lucke, Ingrid Klöting, Hans D. Volk, Rüdiger V. Baehr, Tibor Diamantstein
Eur J Immunol 17(7):1075. [CrossRef]

Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning
Mireille Dardenne, Françoise Lepault, Albert Bendelac, Jean-François Bach
Eur J Immunol 19(5):889. [CrossRef]